Related Experiment Video
Updated: Sep 19, 2025

Genetic Studies of Human DNA Repair Proteins Using Yeast as a Model System
Published on: March 18, 2010
Targeting Werner Syndrome Helicase with Small Molecules in Mismatch Repair-Deficient Cancers
1Usona Institute, Fitchburg, Wisconsin 53711-5300, United States.
Abstract:
Recent efforts have identified WRN helicase as a critical dependency in mismatch repair-deficient (dMMR) cancers. Small molecules targeting WRN demonstrate selective activity in microsatellite instability-high (MSI-H) models. These compounds impair tumor growth and promote cancer cell death by disrupting genome maintenance pathways, highlighting a promising therapeutic strategy for genetically defined, treatment-resistant tumors.
Insights
Targeting WRN helicase shows promise for treating mismatch repair-deficient cancers. These WRN-targeting drugs selectively impair tumor growth in microsatellite instability-high models, offering a new strategy for resistant tumors.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- WRN helicase is crucial for DNA repair.
- Deficiency in mismatch repair (dMMR) creates a dependency on WRN helicase.
- This dependency is particularly relevant in microsatellite instability-high (MSI-H) cancers.
Related Concept Videos
Mismatch Repair
Targeted Cancer Therapies
There are several types of targeted therapies against...
Base Excision Repair
The first step of...
DNA Helicases
Long-patch Base Excision Repair
DNA Damage can Stall the Cell Cycle

